Wang JJ - Search Results

1

Therapeutic potential of angiostatin in diabetic nephropathy.

Zhang SX, Wang JJ, Lu K, Mott R, Longeras R, Ma JX. Zhang SX, et al. Among authors: wang jj. J Am Soc Nephrol. 2006 Feb;17(2):475-86. doi: 10.1681/ASN.2005020217. Epub 2006 Jan 4. J Am Soc Nephrol. 2006. PMID: 16394111

2

Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy.

Wang JJ, Zhang SX, Lu K, Chen Y, Mott R, Sato S, Ma JX. Wang JJ, et al. Diabetes. 2005 Jan;54(1):243-50. doi: 10.2337/diabetes.54.1.243. Diabetes. 2005. PMID: 15616035

3

Systemic and periocular deliveries of plasminogen kringle 5 reduce vascular leakage in rat models of oxygen-induced retinopathy and diabetes.

Zhang SX, Sima J, Wang JJ, Shao C, Fant J, Ma JX. Zhang SX, et al. Among authors: wang jj. Curr Eye Res. 2005 Aug;30(8):681-9. doi: 10.1080/02713680590934102. Curr Eye Res. 2005. PMID: 16109649

4

Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor.

Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX. Zhang SX, et al. Among authors: wang jj. FASEB J. 2006 Feb;20(2):323-5. doi: 10.1096/fj.05-4313fje. Epub 2005 Dec 20. FASEB J. 2006. PMID: 16368716

5

Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.

Wang JJ, Zhang SX, Mott R, Knapp RR, Cao W, Lau K, Ma JX. Wang JJ, et al. Diabetes. 2006 Jun;55(6):1678-85. doi: 10.2337/db05-1448. Diabetes. 2006. PMID: 16731830

6

Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.

Zhang SX, Wang JJ, Gao G, Parke K, Ma JX. Zhang SX, et al. Among authors: wang jj. J Mol Endocrinol. 2006 Aug;37(1):1-12. doi: 10.1677/jme.1.02008. J Mol Endocrinol. 2006. PMID: 16901919

7

Down-regulation of angiogenic inhibitors: a potential pathogenic mechanism for diabetic complications.

Ma JX, Zhang SX, Wang JJ. Ma JX, et al. Among authors: wang jj. Curr Diabetes Rev. 2005 May;1(2):183-96. doi: 10.2174/1573399054022839. Curr Diabetes Rev. 2005. PMID: 18220594 Review.

8

Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.

Wang JJ, Zhang SX, Mott R, Chen Y, Knapp RR, Cao W, Ma JX. Wang JJ, et al. Am J Physiol Renal Physiol. 2008 May;294(5):F1166-73. doi: 10.1152/ajprenal.00375.2007. Epub 2008 Mar 5. Am J Physiol Renal Physiol. 2008. PMID: 18322021 Free article.

9

Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein.

Zhang SX, Wang JJ, Dashti A, Wilson K, Zou MH, Szweda L, Ma JX, Lyons TJ. Zhang SX, et al. Among authors: wang jj. J Mol Endocrinol. 2008 Sep;41(3):135-43. doi: 10.1677/JME-08-0011. Epub 2008 Jun 27. J Mol Endocrinol. 2008. PMID: 18586837 Free PMC article.

10

Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.

Li J, Wang JJ, Chen D, Mott R, Yu Q, Ma JX, Zhang SX. Li J, et al. Among authors: wang jj. Exp Eye Res. 2009 Jun 15;89(1):71-8. doi: 10.1016/j.exer.2009.02.013. Epub 2009 Feb 28. Exp Eye Res. 2009. PMID: 19254713 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,313 results

Search Page

Filters